|
|
Volumn 97, Issue 11, 1996, Pages 2562-2568
|
|
Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators
a
|
|
Author keywords
cyclooxygenase; nitric oxide; platelet aggregation; prostacyclin
|
|
Indexed keywords
6 OXOPROSTAGLANDIN F1 ALPHA;
ANTITHROMBOCYTIC AGENT;
CYCLIC GMP;
GLYCERYL TRINITRATE;
HEMOGLOBIN;
INDOMETACIN;
LINSIDOMINE;
METHYLENE BLUE;
MOLSIDOMINE;
NITRIC OXIDE;
NITROPRUSSIDE SODIUM;
PROSTACYCLIN;
PROSTAGLANDIN SYNTHASE;
VASODILATOR AGENT;
VERAPAMIL;
ANIMAL CELL;
ANIMAL EXPERIMENT;
AORTA;
ARTICLE;
BLOOD VESSEL TONE;
CONTROLLED STUDY;
DRUG MECHANISM;
ENDOTHELIUM CELL;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
HEART RATE;
HUMAN;
HUMAN CELL;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MEAN ARTERIAL PRESSURE;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
THROMBOCYTE AGGREGATION INHIBITION;
VASODILATATION;
|
|
EID: 0029894331
PISSN: 00219738
EISSN: None
Source Type: Journal
DOI: 10.1172/JCI118704 Document Type: Article |
|
Times cited : (158)
|
|
References (0)
|
